Authors: KOBLIN BA HEAGERTY P SHEON A BUCHBINDER S CELUM C DOUGLAS JM GROSS M MARMOR M MAYER K METZGER D SEAGE G

Citation: Ba. Koblin et al., READINESS OF HIGH-RISK POPULATIONS IN THE HIV NETWORK FOR PREVENTION TRIALS TO PARTICIPATE IN HIV VACCINE EFFICACY TRIALS IN THE UNITED-STATES, AIDS, 12(7), 1998, pp. 785-793

Authors: HENNESSY M MACQUEEN K MCKIRNAN DJ BUCHBINDER S JUDSON F DOUGLAS JM BARTHOLOW B SHEON A

Citation: M. Hennessy et al., A FACTORIAL SURVEY STUDY TO ASSESS THE ACCEPTABILITY OF HIV VACCINE TRIAL DESIGNS, Controlled clinical trials, 17(3), 1996, pp. 209-220

Authors: COOPER ER NUGENT RP DIAZ C PITT J HANSON C KALISH LA MENDEZ H ZORRILLA C HERSHOW R MOYE J SMERIGLIO V FOWLER MG RICH K TURPIN D PACHECOACOSTA E TUOMALA R MESTHENE D FOX H HIGGINS A LANDESMAN S MOROSO G WILLOUGHBY A SHEON A MCKINLAY S SHERRIEB K

Citation: Er. Cooper et al., AFTER AIDS CLINICAL-TRIAL-076 - THE CHANGING PATTERN OF ZIDOVUDINE USE DURING PREGNANCY, AND THE SUBSEQUENT REDUCTION IN THE VERTICAL TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS IN A COHORT OF INFECTED WOMEN AND THEIR INFANTS, The Journal of infectious diseases, 174(6), 1996, pp. 1207-1211

Authors: LAWRENCE DN RIDA WN SHEON A FISCHER RD HOFF R

Citation: Dn. Lawrence et al., HELD IN CONJUNCTION WITH THE CONFERENCE ON ADVANCES IN AIDS VACCINE DEVELOPMENT 5TH ANNUAL-MEETING, NATIONAL COOPERATIVE VACCINE DEVELOPMENT GROUPS ON AIDS (CHANTILLY, VIRGINIA, AUGUST 30-SEPTEMBER 2, 1992), AIDS research and human retroviruses, 9, 1993, pp. 190000125-190000126